← All insights

Cross-Border

Chinese Outbound Investment into Europe: A 2025 Update

Marcus T. Okafor·February 11, 2025·8 min read

"The China–Europe deal corridor is open but narrower. The deals getting done share a recognizable profile and a more deliberate regulatory strategy."

Chinese outbound M&A into Europe is a smaller, more selective channel in 2025 than it was at the peak of the 2016–2018 cycle. Aggregate deal value is materially lower; average deal size is smaller; and the sector mix has shifted away from the trophy industrial and consumer assets that dominated the earlier cycle toward more focused investments in industrial automation, certain renewable-energy adjacencies, and specialty chemicals. The deals are still happening; they look different.

The regulatory environment has driven much of the change. The EU FDI Screening Regulation, combined with national FDI regimes in twenty-two of twenty-seven Member States, has created a procedural reality that requires careful coordination. Chinese investors are now routinely subject to filings in three or four jurisdictions on a single transaction, each with its own substantive standard and timetable. The transactions that close are the ones that engaged FDI counsel at term-sheet stage and ran the filings in parallel.

The substantive standards across European FDI regimes have converged in their treatment of Chinese investment, though the language remains national. The default expectation in 2025 is that any meaningful Chinese investment in a European target with operations in sensitive sectors will draw substantive review and may attract conditions. The conditions that have been imposed have followed a recognizable pattern: governance commitments (board composition, information flow restrictions), technology safeguards (export-control compliance, IP-handling), and sometimes commitments around continued European operations and employment.

The CFIUS dimension is increasingly relevant for transactions with any U.S. nexus, including deals where the target's U.S. presence is modest or indirect. The U.S. authorities and major European authorities appear to be coordinating informally, and parties should expect substantive consistency in how a single transaction is reviewed across the Atlantic. The implication for deal planning is that the regulatory analysis needs to begin with a comprehensive jurisdictional map, not with the home jurisdiction of the target.

The transaction structures that work in this environment share several features. They use European-domiciled acquisition vehicles with experienced European management. They include credible commitments around governance and operational autonomy of the European target. They are accompanied by a documentary narrative - strategic rationale, integration plan, supply-chain commitments - drafted with the understanding that European regulators will read it. And they are paced with realistic regulatory timelines built into the closing schedule.

Financing structures have also adapted. The use of European bank financing - sometimes layered with Chinese policy bank participation behind a European-facing tranche - has become more common as a way of demonstrating European capital market alignment. The financing condition has been drafted with explicit awareness of the regulatory timetable, often with extension rights tied to the longer-pole regulatory clearances.

Sellers, particularly European industrial families and sponsor-owned businesses with strategic European positions, have become more selective about Chinese counterparties - but not exclusionary. The deals that close are typically with Chinese investors who have an existing European track record, a credible operational thesis, and a willingness to accept governance commitments that meaningfully constrain post-closing flexibility. The transactional cost of those constraints is meaningful, but for the right asset and the right buyer, the constraints are accepted as the price of access.

Our practical guidance for Chinese investors and their European counterparties in 2025 is to plan the regulatory workstream as the primary timeline driver, structure the transaction with credible operational commitments from the start, and engage the regulators early in complex matters. The China–Europe corridor remains open. It rewards deliberate process and penalizes improvisation.

What we are watching

We will return to this topic across the coming quarter. If you are actively negotiating a transaction where these issues are live, we'd welcome a confidential conversation.

Three takeaways

  • The market is settling, but the diligence bar is rising.
  • Preparation, not posture, is the source of speed.
  • The right structure can move price more than another round of negotiation.

Author

Marcus T. Okafor

Partner · Cross-Border M&A

Read full bio →

Related